Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case reports of fighting immobilization: The paradoxical contribution of flaccid and tonic immobility to the fight.

Psychological trauma : theory, research, practice and policy·2026
Same author

Precision risk stratification of primary gastric cancer after eradication of <i>H. pylori</i> by a DNA methylation marker: a multicentre prospective study.

Gut·2025
Same author

Comparison of the Gut Microbiota of Patients Who Improve with Antibiotic Combination Therapy for Ulcerative Colitis and Those Who Do Not: Investigation by Fecal Metagenomic Analyses.

Nutrients·2024
Same author

The neurobiological effects of childhood maltreatment on brain structure, function, and attachment.

European archives of psychiatry and clinical neuroscience·2024
Same author

Antimicrobial-resistant Helicobacter pylori in Japan: Report of nationwide surveillance for 2018-2020.

Helicobacter·2023
Same author

Endoscopic classification of chronic gastritis based on a pilot study by the research society for gastritis.

Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society·2023
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Related Experiment Video

Updated: Jan 13, 2026

Three-dimensional Quantification of Intestinal Mucus Using Whole-mount Tissue Imaging
05:10

Three-dimensional Quantification of Intestinal Mucus Using Whole-mount Tissue Imaging

Published on: September 12, 2025

447

[Mucosal protective drugs].

Toshiro Sugiyama

    Nihon Rinsho. Japanese Journal of Clinical Medicine
    |July 14, 2015
    PubMed
    Summary
    This summary is machine-generated.

    New treatments for acid-related diseases include proton pump inhibitors for GERD and specific strategies for peptic ulcers based on H. pylori or NSAID use. Alginate-raft formulations effectively manage GERD symptoms, while mucosal protectants aid healing and prevention.

    More Related Videos

    Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins
    09:24

    Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins

    Published on: June 14, 2016

    26.9K
    Ex Vivo Intestinal Sacs to Assess Mucosal Permeability in Models of Gastrointestinal Disease
    06:04

    Ex Vivo Intestinal Sacs to Assess Mucosal Permeability in Models of Gastrointestinal Disease

    Published on: February 9, 2016

    22.0K

    Related Experiment Videos

    Last Updated: Jan 13, 2026

    Three-dimensional Quantification of Intestinal Mucus Using Whole-mount Tissue Imaging
    05:10

    Three-dimensional Quantification of Intestinal Mucus Using Whole-mount Tissue Imaging

    Published on: September 12, 2025

    447
    Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins
    09:24

    Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins

    Published on: June 14, 2016

    26.9K
    Ex Vivo Intestinal Sacs to Assess Mucosal Permeability in Models of Gastrointestinal Disease
    06:04

    Ex Vivo Intestinal Sacs to Assess Mucosal Permeability in Models of Gastrointestinal Disease

    Published on: February 9, 2016

    22.0K

    Area of Science:

    • Gastroenterology
    • Pharmacology

    Background:

    • Acid-related diseases like GERD and peptic ulcers require effective management strategies.
    • Proton pump inhibitors are standard for GERD, while peptic ulcer treatment depends on etiology (H. pylori or NSAIDs).

    Purpose of the Study:

    • To review established and emerging therapeutic strategies for GERD and peptic ulcer disease.
    • To highlight the efficacy of alginate-raft formulations for GERD symptom relief.
    • To discuss the role of mucosal protective drugs in managing H. pylori-related and NSAID-induced ulcers.

    Main Methods:

    • Review of current therapeutic guidelines and clinical trial data.
    • Analysis of evidence for alginate-raft formulations in GERD management.
    • Evaluation of randomized controlled trials on mucosal protective agents for ulcer healing and prevention.

    Main Results:

    • Proton pump inhibitors remain first-line for GERD.
    • Alginate-raft formulations provide symptomatic relief for GERD.
    • Mucosal protective drugs accelerate healing of H. pylori-related ulcers post-eradication.
    • Misoprostol and similar agents show preventive effects against NSAID-induced ulcers with reduced bleeding risk.

    Conclusions:

    • Established treatments for GERD and peptic ulcers are effective.
    • Alginate-raft formulations offer a valuable option for GERD symptom control.
    • Mucosal protective drugs represent a promising therapeutic avenue for specific ulcer types, particularly in NSAID users.